000 | 01132 a2200361 4500 | ||
---|---|---|---|
005 | 20250513231317.0 | ||
264 | 0 | _c20010222 | |
008 | 200102s 0 0 eng d | ||
022 | _a1088-0224 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBishai, W | |
245 | 0 | 0 |
_aRoundtable discussion. Optimizing the use of antimicrobial therapy. _h[electronic resource] |
260 |
_bThe American journal of managed care _cDec 2000 |
||
300 |
_aS1222-35 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aDrug Resistance, Microbial _xgenetics |
650 | 0 | 4 | _aEconomics, Pharmaceutical |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLength of Stay |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aBrueggemann, A B | |
700 | 1 | _aNicolau, D P | |
700 | 1 | _aSteinberg, I | |
700 | 1 | _aSpiritus, E | |
700 | 1 | _aTanigawa, C | |
700 | 1 | _aKoenig, S | |
700 | 1 | _aChaisson, R E | |
700 | 1 | _aBrowne, B A | |
700 | 1 | _aYoder, D M | |
773 | 0 |
_tThe American journal of managed care _gvol. 6 _gno. 23 Suppl _gp. S1222-35 |
|
999 |
_c11125649 _d11125649 |